University of Texas at Austin Human Performance Laboratory
Austin, Texas, 78712, United States
NCT Number: NCT04448925
The optimal recovery duration depends on the intensity of exercise and in the present study the intensity was maximal power for 4-s while cycling an 'Inertial Load' ergometer (ILE). Recovery duration of 15, 30 and 45-s were given between 30 successive sprints.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Austin, Texas, 78712, United States
All subjects completed an informed consent for this study that was approved by the Institutional Review Board of the University of Texas at Austin.
Study Overview. A randomized, cross-over experimental design was conducted. Each participant visited the laboratory on four occasions which were separated by two to five days. Measurement of body mass, familiarization with experimental procedures and cycling peak oxygen consumption test (VO2peak) were performed on the first visit. Participants took part in inertial-load exercise (ILE) on the remaining test days. On each separate session, a different inter-sprint recovery duration was employed (i.e. 15, 30 or 45-s). Cycling power output, pulmonary gas exchange, vastus lateralis de-oxygenation status, heart rate and blood lactate were measured.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Length of time between exercise bouts
Time frame: 10 min
University of Texas at Austin
Other
Physiological Responses to Maximal 4-s Sprint Interval Cycling Using Inertial Loading: the Influence of Inter-sprint Recovery Duration
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07149272
Behavior, Fatigue
Jakarta Pusat, Jakarta Special Capital Region, Indonesia
View Trial DetailsNCT01294332
Behavior, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04550676
Acquired Immunodeficiency Syndrome, Behavior
Aurora, Colorado, United States
View Trial DetailsNCT06994104
Behavior, Behavior, Addictive
Istanbul, Marmara, Turkey (Türkiye)
View Trial Details